Showing posts with label preventive medicine. Show all posts
Showing posts with label preventive medicine. Show all posts

Preventive Services Regulations Issued



Today’s Managing Health Care Costs Indicator is

1.5%


The Obama Administration has announced regulations  clarifying the new requirement that health plans cover preventive care without copayments.   The regulations were announced less than four months after the passage of the Patient Protection and Affordable Care Act (PPACA), and apply to health plans that are not “grandfathered.”   Last week, the administration announced regulations around grandfathering, clarifying which changes in benefit design  will mean a plan will no longer be grandfathered.

There are three categories of required covered services
  1. 1.     Those rated “A” or “B” by the US Preventive Services Task Force.   This list ranges from screening for cancer to providing folic acid supplements to women considering pregnancy to giving aspirin to prevent heart attacks. 
  2. 2.     Immunizations recommended by the Centers for Disease Control and Prevention.  This includes pediatric and adult vaccines.
  3. 3.     Recommendations from the Health Resources and Services Administration (HRSA) regarding preventive care for children  . Recommendations for women’s health are expected in early 2011.


Here’s a link to the complete list of required covered services. 

This is good news for health care.  Preventive services are among the most cost-effective services available in health care. Further, they are terribly underused. For instance, less than 7% (!) of adults get the Zoster vaccine to prevent shingles, a painful complication from childhood chickenpox that often affects adults over 50. 

This is good news for patients, since eliminating financial barriers will increase the use of these services than can help patients live better lives.

The regulations will cause some angst at health plans, where new systems will have to be developed to arrange for payment for a number of nonprescription drugs which have previously not been covered.  

Some intuitively believe that covering more preventive services will save money.  Some of these services (pediatric immunizations) are indeed cost saving.   However, most are cost-effective – so that there will be incremental cost, but it will be modest compared to the benefits.

The Obama Administration is being honest here, and says that these new regulations will increase health care costs by 1.5%.   To put this in perspective, employer-sponsored health care costs about $700 billion per year, so this type of an increase would cost $10.5 billion.  This isn’t a small amount, but it’s an investment well worth making.








Prostate Cancer Screening: Rough Estimate of the Cost

Two studies in last week’s  New England Journal Of Medicine showed disappointing results from prostate cancer screening. This is a reminder that investments in preventive care are not always a good idea.  The United States study, completed in 10 centers, included 77,000 patients and showed a nonsignificant increase in death rates among those patients who were randomly assigned to screening.  The European study, an amalgam of seven different studies which had different designs, included 182,000 patients, and did show a decrease in death from prostate cancer of 7 per 10,000. However, 49 men were treated for prostate cancer for each life saved – leading to an enormous amount of incontinence and impotence. 

 

I’ll turn 50 next year – and it’s not looking like I’ll be getting my first PSA test!

 

The morbidity from all prostate cancer treatment is considerable – whether prostate removal (radical prostatectomy) or radiation (either external beam or implantation of radiation ‘seeds’).  There is has been little written about the cost of the increased cancer diagnosis from  prostate cancer screening – so I figured I would provide some “back of the envelope” guesstimates of the cost of our prostate cancer screening.

 

Population:  18.7 million  ages 50-59 (United States)


Increased Cancer Diagnoses: 3.4% (8.2% in the screening group and 4.8% in the control group)


è Increased Cancer diagnoses: 638,542 for this population over about a decade

 

Distribution of Treatment (and associated cost)

Wilson, et al Cumulative cost pattern comparison of prostate cancer treatments, Cancer 109: 18-527


Note that this is Medicare data, so this understates the cost compared to a population under 65.

 

è Total excess cost over 10 years for this population: $27 billion

 

That’s not a trivial figure even in these days of massive corporate bailouts.


 

 

%age

Cost

#

Spend

Radical Prostatectomy

55%

 $        36,888

         350,055

 $  12,912,828,840

Cryotherapy

3%

 $        43,108

           18,933

 $        816,163,764

Brachytherapy

15%

 $        35,143

           93,684

 $    3,292,336,812

External Beam

9%

 $        59,455

           57,360

 $    3,410,338,800

Androgen

13%

 $        69,244

           85,129

 $    5,894,672,476

Watchful Wait

5%

 $        32,135

           33,378

 $    1,072,602,030

TOTAL INCREASED SPENDING

 

 

 

 $  27,398,942,722